Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) - Stock analysts at Zacks Research upped their FY2026 earnings per share estimates for shares of Pediatrix Medical Group in a research report issued to clients and investors on Monday, March 10th. Zacks Research analyst Z. Masood now anticipates that the company will earn $1.44 per share for the year, up from their prior estimate of $1.43. The consensus estimate for Pediatrix Medical Group's current full-year earnings is $1.38 per share.
Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.37 by $0.12. The firm had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%.
Several other analysts have also weighed in on MD. UBS Group increased their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a report on Friday, February 21st. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Truist Financial increased their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a report on Friday, February 21st. Mizuho increased their price target on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a report on Tuesday, November 19th. Finally, Macquarie started coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an "outperform" rating and a $18.00 price target on the stock. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $17.08.
Check Out Our Latest Stock Report on MD
Pediatrix Medical Group Price Performance
Shares of NYSE MD traded up $0.54 during midday trading on Thursday, reaching $14.26. 652,972 shares of the stock traded hands, compared to its average volume of 803,734. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The stock has a market capitalization of $1.22 billion, a PE ratio of -11.89, a P/E/G ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group has a one year low of $6.62 and a one year high of $17.67. The company's 50 day moving average is $14.16 and its 200 day moving average is $13.43.
Institutional Investors Weigh In On Pediatrix Medical Group
Institutional investors have recently added to or reduced their stakes in the stock. State Street Corp boosted its holdings in Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company's stock worth $41,038,000 after acquiring an additional 50,597 shares in the last quarter. Nordea Investment Management AB boosted its holdings in Pediatrix Medical Group by 51.6% in the fourth quarter. Nordea Investment Management AB now owns 263,633 shares of the company's stock worth $3,504,000 after acquiring an additional 89,739 shares in the last quarter. Barclays PLC boosted its holdings in Pediatrix Medical Group by 302.9% in the third quarter. Barclays PLC now owns 142,087 shares of the company's stock worth $1,646,000 after acquiring an additional 106,817 shares in the last quarter. Franklin Resources Inc. acquired a new stake in Pediatrix Medical Group in the third quarter worth about $598,000. Finally, Principal Financial Group Inc. boosted its holdings in Pediatrix Medical Group by 14.1% in the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company's stock worth $5,953,000 after acquiring an additional 63,581 shares in the last quarter. Institutional investors own 97.71% of the company's stock.
Pediatrix Medical Group Company Profile
(
Get Free Report)
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Read More
Before you consider Pediatrix Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.
While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
